{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T20:52:11Z","timestamp":1769201531692,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.cllc.2012.12.006","type":"journal-article","created":{"date-parts":[[2013,3,12]],"date-time":"2013-03-12T23:11:13Z","timestamp":1363129873000},"page":"407-417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Nested Case Control Study of Proteomic Biomarkers for Interstitial Lung Disease in Japanese Patients With Non\u2013Small-Cell Lung Cancer Treated With Erlotinib: A Multicenter Phase IV Study (JO21661)"],"prefix":"10.1016","volume":"14","author":[{"given":"Shinji","family":"Atagi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Katakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshige","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Fukuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Kudoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Ogiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeyuki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2012.12.006_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(03)12190-3","article-title":"Severe acute interstitial pneumonia and gefitinib","volume":"361","author":"Inoue","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cllc.2012.12.006_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/s10165-005-0387-9","article-title":"Leflunomide-related lung injury in patients with rheumatoid arthritis: imaging features","volume":"15","author":"Sakai","year":"2005","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.cllc.2012.12.006_bib3","first-page":"1556","article-title":"A case of pneumonitis due to sho-saiko-to","volume":"27","author":"Tsukiyama","year":"1989","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"10.1016\/j.cllc.2012.12.006_bib4","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1164\/ajrccm.177.12.1397a","article-title":"Basis of acute exacerbation of idiopathic pulmonary fibrosis in Japanese patients","volume":"177","author":"Azuma","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cllc.2012.12.006_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1385\/MO:23:2:161","article-title":"Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors","volume":"23","author":"Tsuboi","year":"2006","journal-title":"Med Oncol"},{"key":"10.1016\/j.cllc.2012.12.006_bib6","first-page":"321","article-title":"Drug-induced pulmonary disease. part 1: Cytotoxic drugs","volume":"133","author":"Cooper","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.cllc.2012.12.006_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa050753","article-title":"Erlotinib in previously treated non-small-cell lung cancer","volume":"353","author":"Shepherd","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cllc.2012.12.006_bib8","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","article-title":"Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group","volume":"25","author":"Moore","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2012.12.006_bib9","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1097\/JTO.0b013e3182598abb","article-title":"Postmarketing surveillance study of erlotinib in Japanese patients with non-small-cell lung cancer (NSCLC): an interim analysis of 3488 patients (POLARSTAR)","volume":"7","author":"Nakagawa","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2012.12.006_bib10","first-page":"1439","article-title":"Efficacy and safety of erlotinib monotherapy for Japanese patients with advanced non-small cell lung cancer","volume":"12","author":"Kubota","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2012.12.006_bib11","first-page":"557","article-title":"Phase II study of erlotinib in Japanese patients with advanced non-small cell lung cancer","volume":"30","author":"Takahashi","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cllc.2012.12.006_bib12","doi-asserted-by":"crossref","first-page":"e22062","DOI":"10.1371\/journal.pone.0022062","article-title":"Proteomic biomarkers for acute interstitial lung disease in gefitinib-treated Japanese lung cancer patients","volume":"6","author":"Nyberg","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cllc.2012.12.006_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal Biochem"},{"key":"10.1016\/j.cllc.2012.12.006_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0003-2697(88)90383-1","article-title":"Investigation of the bicinchoninic acid protein assay: identification of the groups responsible for color formation","volume":"175","author":"Wiechelman","year":"1988","journal-title":"Anal Biochem"},{"key":"10.1016\/j.cllc.2012.12.006_bib15","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/jms.856","article-title":"The Orbitrap: a new mass spectrometer","volume":"40","author":"Hu","year":"2005","journal-title":"J Mass Spectrom"},{"key":"10.1016\/j.cllc.2012.12.006_bib16","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2","article-title":"Probability-based protein identification by searching sequence databases using mass spectrometry data","volume":"20","author":"Perkins","year":"1999","journal-title":"Electrophoresis"},{"key":"10.1016\/j.cllc.2012.12.006_bib17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0962280209351908","article-title":"Gene set enrichment analysis made simple","volume":"18","author":"Irizarry","year":"2009","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.cllc.2012.12.006_bib18","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2217\/pgs.11.38","article-title":"Interstitial lung disease in gefitinib-treated Japanese patients with non-small-cell lung cancer: genome-wide analysis of genetic data","volume":"12","author":"Nyberg","year":"2011","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.cllc.2012.12.006_bib19","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1164\/rccm.200710-1501OC","article-title":"Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study","volume":"177","author":"Kudoh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cllc.2012.12.006_bib20","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ijrobp.2010.01.038","article-title":"Plasma proteomic analysis may identify new markers for radiation-induced lung toxicity in patients with non-small-cell lung cancer","volume":"77","author":"Cai","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2012.12.006_bib21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1164\/rccm.200905-0659OC","article-title":"Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis","volume":"182","author":"Kim","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cllc.2012.12.006_bib22","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1002\/1522-2683(20000701)21:13<2703::AID-ELPS2703>3.0.CO;2-W","article-title":"Human bronchoalveolar lavage fluid protein two-dimensional database: study of interstitial lung diseases","volume":"21","author":"Wattiez","year":"2000","journal-title":"Electrophoresis"},{"key":"10.1016\/j.cllc.2012.12.006_bib23","doi-asserted-by":"crossref","first-page":"R160","DOI":"10.1186\/ar2067","article-title":"Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis","volume":"8","author":"Fietta","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cllc.2012.12.006_bib24","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/pmic.200301007","article-title":"Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis","volume":"5","author":"Rottoli","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.cllc.2012.12.006_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ejphar.2008.06.047","article-title":"Human ApoA-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice","volume":"590","author":"Li","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cllc.2012.12.006_bib26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.lfs.2004.10.066","article-title":"Neutrophils activation can be diminished by apolipoprotein A-I","volume":"77","author":"Liao","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.cllc.2012.12.006_bib27","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1200\/JCO.2005.04.9866","article-title":"Predictive factors for interstitial lung disease, antitumor response, and survival in non-small-cell lung cancer patients treated with gefitinib","volume":"24","author":"Ando","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2012.12.006_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1183\/09031936.00087708","article-title":"Lipopolysaccharide-binding protein and CD14 are increased in the bronchoalveolar lavage fluid of smokers","volume":"33","author":"Regueiro","year":"2009","journal-title":"Eur Respir J"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730413000247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730413000247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:03:27Z","timestamp":1761505407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730413000247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1525730413000247"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2012.12.006","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nested Case Control Study of Proteomic Biomarkers for Interstitial Lung Disease in Japanese Patients With Non\u2013Small-Cell Lung Cancer Treated With Erlotinib: A Multicenter Phase IV Study (JO21661)","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2012.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}